Health
A nanoscaffolding approach for rapid design of highly immunogenic SARS-CoV-2 vaccines – News-Medical.net
A research group from Slovenia, Switzerland, and Germany shows how nanoscaffolded assemblies may neutralize interaction between the SARS-CoV-2 spike protein and cell receptor, providing adequate protection in a surrogate infection assay and warranting the adv…
A research group from Slovenia, Switzerland, and Germany shows how nanoscaffolded assemblies may neutralize interaction between the SARS-CoV-2 spike protein and cell receptor, providing adequate protection in a surrogate infection assay and warranting the advance of such platforms in the pursuit for the effective vaccine. Their results are currently available on bioRxiv* preprint server.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative agent of the ongoing COVID-19 pa…
-
Noosa News21 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News23 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General20 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win
-
General13 hours agoDavid Littleproud’s own goal • Inside Story